Manufacturer
Uronova Pharmaceuticals
- Products listed
- 4
- Molecules
- 1
- Therapy areas
- 1
Uronova Pharmaceuticals is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 4 of its products across 1 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Indian manufacturer
- No
- Also listed as
- Uronova Pharmaceuticals, INC.
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Uronova Pharmaceuticals products through licensed channels, with the documents your regulator needs.
Oncology
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Vabrinty 22.5 mg/0.375 mL extended-release injectable suspensionSubcutaneous Cold chain | Leuprolide | US FDA | Available on request |
| Vabrinty 30 mg/0.5 mL extended-release injectable suspensionSubcutaneous Cold chain | Leuprolide | US FDA | Available on request |
| Vabrinty 45 mg/0.375 mL extended-release injectable suspensionSubcutaneous Cold chain | Leuprolide | US FDA | Available on request |
| Vabrinty 7.5 mg/0.25 mL extended-release injectable suspensionSubcutaneous Cold chain | Leuprolide | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Uronova Pharmaceuticals
Send a request for any of these products. We confirm the licensed source, documents and lead time.